Skip to content

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Patients with Laryngeal Surgery

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Patients with Laryngeal Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062613
Enrollment
Unknown
Registered
2022-08-14
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laryngomalacia

Interventions

Intervention group:High-flow nasal cannula oxygen therapy
Control:The standard nasal catheter oxygen therapy

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 6 Years

Inclusion criteria

Inclusion criteria: 1. Aged 3 months - 6 years; 2. Children with ASA grade 1-3; 3. Incision with spontaneous breathing and no air before operation; 4. Children who need to maintain spontaneous breathing without tracheal intubation during surgery or treatment; 5. The subjects or guardians voluntarily participated in the experiment and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe facial deformity; 2. Risk of regurgitation and aspiration; 3. Difficulty in mask ventilation and intubation; 4. Children whose preoperative oxygenation could not be maintained and needed auxiliary ventilation; 5. Children who refused to cooperate with the treatment or refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
arterial blood gases;lowest SpO2;

Secondary

MeasureTime frame
Vital signs;operation time;

Countries

China

Contacts

Public ContactYing Xu

Children's Hospital of Chongqing Medical University

xuyingxy3066@126.com+86 13983409393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026